scholarly journals Effects of Medicare payment reform: Evidence from the home health interim and prospective payment systems

2014 ◽  
Vol 34 ◽  
pp. 1-18 ◽  
Author(s):  
Peter J. Huckfeldt ◽  
Neeraj Sood ◽  
José J. Escarce ◽  
David C. Grabowski ◽  
Joseph P. Newhouse
2012 ◽  
Author(s):  
Peter J. Huckfeldt ◽  
Neeraj Sood ◽  
Jose Escarce ◽  
David C. Grabowski ◽  
Joseph P. Newhouse

2012 ◽  
Author(s):  
Peter Huckfeldt ◽  
Neeraj Sood ◽  
José Escarce ◽  
David Grabowski ◽  
Joseph Newhouse

2005 ◽  
Vol 16 (3) ◽  
pp. 576-587 ◽  
Author(s):  
Chyongchiou Jeng Lin ◽  
Joan K. Davitt ◽  
Michael Meit ◽  
Myron Schwartz ◽  
Jonas Marainen ◽  
...  

Author(s):  
Gerard F. Anderson Anderson ◽  
Karen Davis Davis ◽  
Stuart Guterman Guterman

2005 ◽  
Vol 37 (1) ◽  
pp. 73-79 ◽  
Author(s):  
Mary Ann Anderson ◽  
Mara M. Clarke ◽  
Lelia B. Helms ◽  
Marquis D. Foreman

2002 ◽  
Vol 5 (1) ◽  
Author(s):  
David Meltzer ◽  
Jeanette Chung

Competition and prospective payment systems have been widely used to attempt to control health care costs. Although much of the increase in medical costs over the past half-century has been concentrated among a few high-cost users of health care, prospective payment systems may provide incentives to reduce expenditures selectively on high-cost users relative to low-cost users, and this pressure may be increased by competition. We use data on hospital charges and cost-to-charge ratios from California in 1983 and 1993 to examine the effects of competition on costs for high- and low-cost admissions before and after the establishment of the Medicare Prospective Payment System (PPS). Comparing persons above and below age 65 before and after the establishment of PPS, we find that competition is associated with increased costs before PPS in both age groups, but decreased costs afterwards, especially among those above age 65 with the highest costs. We conclude that the combination of competition and prospective payment systems may result in incentives to reduce spending selectively among the most expensive patients. This conclusion raises important issues relevant to the use of competition and prospective payment to control costs. It also implies that, at minimum, there is a need to carefully monitor outcomes for the sickest patients under prospective payment systems in competitive environments.


Sign in / Sign up

Export Citation Format

Share Document